Trial Profile
An Open-Label, Single/Multiple Dose, Non-Randomized, 3-Period, Crossover Study To Determine The Potential Drug Interaction Of Bazedoxifene On Conjugated Estrogens (CE) in Healthy Postmenopausal Women
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 25 Jun 2010
Price :
$35
*
At a glance
- Drugs Bazedoxifene (Primary) ; Conjugated estrogens
- Indications Menopausal syndrome
- Focus Pharmacokinetics
- Sponsors Wyeth
- 21 Jun 2010 Actual end date (Jul 2008) added as reported by ClinicalTrials.gov.
- 21 Jun 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 23 Jul 2008 New trial record.